Overview
Also known as:
FDA & Trial Timeline
3 eventsShanghai Jiao Tong University School of Medicine — PHASE3
Instituto de Investigacion Sanitaria La Fe
Purixan: FDA approved
Treatment of patients with acute lymphoblastic leukemia as part of a combination regimen.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Acute myeloblastic leukemia with maturation.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesTAFINLAR
Novartis Pharmaceuticals Corp.
TAFINLAR Patient Support (Novartis Patient Assistance)
Purixan
Nova Laboratories Limited
Purixan — Contact Nova Laboratories Limited
Travel Grants
No travel grants are currently matched to Acute myeloblastic leukemia with maturation.
Community
No community posts yet. Be the first to share your experience with Acute myeloblastic leukemia with maturation.
Start the conversation →Latest news about Acute myeloblastic leukemia with maturation
Disease timeline:
New recruiting trial: Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan
A new clinical trial is recruiting patients for Acute myeloblastic leukemia with maturation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Acute myeloblastic leukemia with maturation
Are there clinical trials for Acute myeloblastic leukemia with maturation?
Yes — 1 recruiting clinical trial is currently listed for Acute myeloblastic leukemia with maturation on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Acute myeloblastic leukemia with maturation?
23 specialists and care centers treating Acute myeloblastic leukemia with maturation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Acute myeloblastic leukemia with maturation?
2 patient support programs are currently tracked on UniteRare for Acute myeloblastic leukemia with maturation. See the treatments and support programs sections for copay assistance, eligibility, and contact details.